BHC

Bausch Health Companies Inc.

Insider trading activity for Bausch Health Companies Inc., straight from SEC Form 4 filings. Net figures below count open-market buys and sales only — grants, option exercises and tax withholding are excluded because they are compensation, not decisions to trade.

Past 3 months

-$258.9K

net selling

Bought(0 · 0 insiders): $0
Sold(1 · 1 insiders): $258.9K

Past 6 months

-$391.7K

net selling

Bought(0 · 0 insiders): $0
Sold(2 · 2 insiders): $391.7K

Past 12 months

+$15.1M

net buying

Bought(1 · 1 insiders): $15.6M
Sold(5 · 3 insiders): $506.7K

Transaction history

The 75 most recent Form 4 transactions.

Open in screener →

Insider transactions, newest first: date, security, transaction type, size and a link to the filing each row came from.
Date	Insider	Role	Type	Shares	Price	Value	Δ Own	Filing
Aug 19	Lenar Aimee J.	President, US Pharma	SSELL◷	36,827	$7.03	$258.9K	-9.9%	Open the original filing on SEC.gov
Jul 17	Lenar Aimee J.	President, US Pharma	FTAX	5,260	$4.83	$25.4K	-1.4%	Open the original filing on SEC.gov
Jul 15	Lenar Aimee J.	President, US Pharma	FTAX	23,395	$4.89	$114.4K	-5.8%	Open the original filing on SEC.gov
Jul 14	Lee Steven Hyosig	SVP, Controller & CAO	FTAX	3,125	$4.75	$14.8K	-4.3%	Open the original filing on SEC.gov
Jun 30	Wechsler Amy B	Director	AGRANT	1,394	$4.93	$6.9K	+0.4%	Open the original filing on SEC.gov
Jun 30	Paulson John	Director	AGRANT	12,677	$4.93	$62.5K	+3.0%	Open the original filing on SEC.gov
Jun 30	Leung Sandra	Director	AGRANT	6,845	$4.93	$33.7K	+7.6%	Open the original filing on SEC.gov
May 22	Wechsler Amy B	Director	AGRANT	45,871	—	—	+17.1%	Open the original filing on SEC.gov
May 22	Roberts Eiry	Director	AGRANT	45,871	—	—	—	Open the original filing on SEC.gov
May 22	Power Robert N	Director	AGRANT	45,871	—	—	+18.0%	Open the original filing on SEC.gov
May 22	Paulson John	Director	AGRANT	45,871	—	—	+12.3%	Open the original filing on SEC.gov
May 22	Leung Sandra	Director	AGRANT	45,871	—	—	+103.4%	Open the original filing on SEC.gov
May 22	Lee Frank D.	Director	AGRANT	45,871	—	—	+93.0%	Open the original filing on SEC.gov
May 22	Kavanagh Sarah B	Director	AGRANT	45,871	—	—	+19.4%	Open the original filing on SEC.gov
May 22	Goettler Michael	Director	AGRANT	45,871	—	—	+152.2%	Open the original filing on SEC.gov
May 22	Garcia Christian A	Director	AGRANT	45,871	—	—	+51.1%	Open the original filing on SEC.gov
May 19	Lee Frank D.	Director	SSELL◷	24,456	$5.43	$132.8K	-33.1%	Open the original filing on SEC.gov
Mar 31	Leung Sandra	Director	AGRANT	5,946	$5.40	$32.1K	+15.5%	Open the original filing on SEC.gov
Mar 31	Paulson John	Director	AGRANT	11,574	$5.40	$62.5K	+3.2%	Open the original filing on SEC.gov
Mar 31	Wechsler Amy B	Director	AGRANT	1,273	$5.40	$6.9K	+0.5%	Open the original filing on SEC.gov
Mar 3	Carson Seana	EVP, General Counsel	SSELL◷	4,420	$5.77	$25.5K	-0.7%	Open the original filing on SEC.gov
Mar 2	Carson Seana	EVP, General Counsel	JOTHER◷	137,922	$5.95	$820.6K	-18.2%	Open the original filing on SEC.gov
Mar 2	Carson Seana	EVP, General Counsel	FTAX◷	16,973	$5.95	$101K	-2.2%	Open the original filing on SEC.gov
Mar 2	Carson Seana	EVP, General Counsel	SSELL◷	6,856	$5.78	$39.6K	-0.9%	Open the original filing on SEC.gov
Mar 2	Appio Thomas	Chief Executive Officer	JOTHER	1.1M	$5.95	$6.8M	-33.0%	Open the original filing on SEC.gov
Mar 2	Appio Thomas	Chief Executive Officer	FTAX	83,705	$5.95	$498K	-2.4%	Open the original filing on SEC.gov
Feb 27	Carson Seana	EVP, General Counsel	SSELL◷	8,388	$5.95	$49.9K	-1.0%	Open the original filing on SEC.gov
Feb 27	Charhon Jean-Jacques	EVP, CFO	FTAX	49,060	$5.93	$290.9K	-6.5%	Open the original filing on SEC.gov
Feb 27	Carson Seana	EVP, General Counsel	FTAX◷	26,326	$5.93	$156.1K	-3.3%	Open the original filing on SEC.gov
Feb 27	Appio Thomas	Chief Executive Officer	FTAX	83,093	$5.93	$492.7K	-2.3%	Open the original filing on SEC.gov
Feb 26	Lenar Aimee J.	EVP, US Pharma	FTAX	17,578	$6.04	$106.2K	-4.2%	Open the original filing on SEC.gov
Feb 26	Carson Seana	EVP, General Counsel	FTAX◷	32,211	$6.04	$194.6K	-3.8%	Open the original filing on SEC.gov
Feb 26	Charhon Jean-Jacques	EVP, CFO	FTAX	35,977	$6.04	$217.3K	-4.5%	Open the original filing on SEC.gov
Feb 26	Appio Thomas	Chief Executive Officer	FTAX	116,502	$6.04	$703.7K	-3.1%	Open the original filing on SEC.gov
Feb 25	Lee Steven Hyosig	SVP, Controller & CAO	AGRANT	45,868	—	—	+167.6%	Open the original filing on SEC.gov
Feb 25	Lenar Aimee J.	EVP, US Pharma	AGRANT	157,139	—	—	+60.3%	Open the original filing on SEC.gov
Feb 25	Carson Seana	EVP, General Counsel	AGRANT◷	212,350	—	—	+33.3%	Open the original filing on SEC.gov
Feb 25	Charhon Jean-Jacques	EVP, CFO	AGRANT	276,055	—	—	+53.6%	Open the original filing on SEC.gov
Feb 25	Appio Thomas	Chief Executive Officer	AGRANT	815,425	—	—	+27.9%	Open the original filing on SEC.gov
Feb 9	Carson Seana	EVP, General Counsel	AGRANT	137,922	—	—	+27.6%	Open the original filing on SEC.gov
Feb 9	Appio Thomas	Chief Executive Officer	AGRANT	1.1M	—	—	+63.8%	Open the original filing on SEC.gov
Dec 31, 2025	Paulson John	Director	AGRANT	8,992	—	—	+2.6%	Open the original filing on SEC.gov
Dec 31, 2025	Leung Sandra	Director	AGRANT	4,586	—	—	+13.6%	Open the original filing on SEC.gov
Dec 31, 2025	Wechsler Amy B	Director	AGRANT	989	—	—	+0.4%	Open the original filing on SEC.gov
Nov 25, 2025	Paulson & Co. Inc.	10% Owner	PBUY★	2.5M	$6.25	$15.6M	+3.5%	Open the original filing on SEC.gov
Sep 30, 2025	Leung Sandra	Director	AGRANT	3,673	—	—	+12.2%	Open the original filing on SEC.gov
Sep 30, 2025	Wechsler Amy B	Director	AGRANT	1,065	—	—	+0.4%	Open the original filing on SEC.gov
Sep 8, 2025	Carson Seana	EVP, General Counsel	SSELL◷	13,370	$7.31	$97.7K	-2.6%	Open the original filing on SEC.gov
Sep 5, 2025	Carson Seana	EVP, General Counsel	FTAX◷	51,337	$7.35	$377.3K	-9.1%	Open the original filing on SEC.gov
Aug 21, 2025	Lee Frank D.	Director	SSELL	15,912	$7.66	$121.9K	-17.7%	Open the original filing on SEC.gov
Aug 14, 2025	Paulson John	Director	PBUY▲	34.7M	$9.00	$312.5M	+96.4%	Open the original filing on SEC.gov
Aug 13, 2025	Paulson John	Director	PBUY	86,409	$7.06	$610K	+0.2%	Open the original filing on SEC.gov
Aug 12, 2025	Paulson John	Director	PBUY	1.2M	$6.88	$8M	+3.3%	Open the original filing on SEC.gov
Aug 11, 2025	Paulson John	Director	PBUY	2M	$6.35	$12.7M	+6.1%	Open the original filing on SEC.gov
Jul 25, 2025	Goettler Michael	Director	AGRANT	30,149	—	—	—	Open the original filing on SEC.gov
Jul 25, 2025	Leung Sandra	Director	AGRANT	30,149	—	—	—	Open the original filing on SEC.gov
Jul 17, 2025	Lenar Aimee J.	EVP, US Pharma	AGRANT	30,847	—	—	+13.4%	Open the original filing on SEC.gov
Jul 15, 2025	Lenar Aimee J.	EVP, US Pharma	FTAX	22,736	$6.42	$146K	-9.0%	Open the original filing on SEC.gov
Jul 14, 2025	Lee Steven Hyosig	SVP, Controller & CAO	AGRANT	27,371	—	—	—	Open the original filing on SEC.gov
Jun 30, 2025	Paulson John	Director	AGRANT	9,384	—	—	+2.8%	Open the original filing on SEC.gov
Jun 30, 2025	Icahn Brett	Director	AGRANT	4,034	—	—	+1.9%	Open the original filing on SEC.gov
Jun 30, 2025	Wechsler Amy B	Director	AGRANT	1,032	—	—	+0.4%	Open the original filing on SEC.gov
Jun 13, 2025	Paulson John	Director	PBUY▲	3.6M	$5.94	$21.2M	+12.2%	Open the original filing on SEC.gov
Jun 12, 2025	Paulson John	Director	PBUY	1M	$5.47	$5.5M	+3.6%	Open the original filing on SEC.gov
Jun 11, 2025	Paulson John	Director	PBUY	1M	$5.24	$5.4M	+3.8%	Open the original filing on SEC.gov
Jun 10, 2025	Paulson John	Director	PBUY	754,134	$5.05	$3.8M	+2.9%	Open the original filing on SEC.gov
May 16, 2025	Garcia Christian A	Director	AGRANT	54,347	—	—	+153.7%	Open the original filing on SEC.gov
May 16, 2025	Icahn Brett	Director	AGRANT	54,347	—	—	+33.6%	Open the original filing on SEC.gov
May 16, 2025	Kavanagh Sarah B	Director	AGRANT	54,347	—	—	+29.9%	Open the original filing on SEC.gov
May 16, 2025	Lee Frank D.	Director	AGRANT	54,347	—	—	+153.7%	Open the original filing on SEC.gov
May 16, 2025	Miller Steven D	Director	AGRANT	54,347	—	—	+31.1%	Open the original filing on SEC.gov
May 16, 2025	Mulligan Richard	Director	AGRANT	54,347	—	—	+53.7%	Open the original filing on SEC.gov
May 16, 2025	Paulson John	Director	AGRANT	54,347	—	—	+19.6%	Open the original filing on SEC.gov
May 16, 2025	Power Robert N	Director	AGRANT	54,347	—	—	+27.1%	Open the original filing on SEC.gov
May 16, 2025	Wechsler Amy B	Director	AGRANT	54,347	—	—	+26.0%	Open the original filing on SEC.gov

SSELL◷$258.9K

Lenar Aimee J. · President, US…Aug 19

36,827 sh @ $7.03 · -9.9% own

FTAX$25.4K

Lenar Aimee J. · President, US…Jul 17

5,260 sh @ $4.83 · -1.4% own

FTAX$114.4K

Lenar Aimee J. · President, US…Jul 15

23,395 sh @ $4.89 · -5.8% own

FTAX$14.8K

Lee Steven Hyosig · SVP, Controller &…Jul 14

3,125 sh @ $4.75 · -4.3% own

AGRANT$6.9K

Wechsler Amy B · DirectorJun 30

1,394 sh @ $4.93 · +0.4% own

AGRANT$62.5K

Paulson John · DirectorJun 30

12,677 sh @ $4.93 · +3.0% own

AGRANT$33.7K

Leung Sandra · DirectorJun 30

6,845 sh @ $4.93 · +7.6% own

AGRANT—

Wechsler Amy B · DirectorMay 22

45,871 sh · +17.1% own

AGRANT—

Roberts Eiry · DirectorMay 22

45,871 sh

AGRANT—

Power Robert N · DirectorMay 22

45,871 sh · +18.0% own

AGRANT—

Paulson John · DirectorMay 22

45,871 sh · +12.3% own

AGRANT—

Leung Sandra · DirectorMay 22

45,871 sh · +103.4% own

AGRANT—

Lee Frank D. · DirectorMay 22

45,871 sh · +93.0% own

AGRANT—

Kavanagh Sarah B · DirectorMay 22

45,871 sh · +19.4% own

AGRANT—

Goettler Michael · DirectorMay 22

45,871 sh · +152.2% own

AGRANT—

Garcia Christian A · DirectorMay 22

45,871 sh · +51.1% own

SSELL◷$132.8K

Lee Frank D. · DirectorMay 19

24,456 sh @ $5.43 · -33.1% own

AGRANT$32.1K

Leung Sandra · DirectorMar 31

5,946 sh @ $5.40 · +15.5% own

AGRANT$62.5K

Paulson John · DirectorMar 31

11,574 sh @ $5.40 · +3.2% own

AGRANT$6.9K

Wechsler Amy B · DirectorMar 31

1,273 sh @ $5.40 · +0.5% own

SSELL◷$25.5K

Carson Seana · EVP, General…Mar 3

4,420 sh @ $5.77 · -0.7% own

JOTHER◷$820.6K

Carson Seana · EVP, General…Mar 2

137,922 sh @ $5.95 · -18.2% own

FTAX◷$101K

Carson Seana · EVP, General…Mar 2

16,973 sh @ $5.95 · -2.2% own

SSELL◷$39.6K

Carson Seana · EVP, General…Mar 2

6,856 sh @ $5.78 · -0.9% own

JOTHER$6.8M

Appio Thomas · Chief Executive…Mar 2

1.1M sh @ $5.95 · -33.0% own

FTAX$498K

Appio Thomas · Chief Executive…Mar 2

83,705 sh @ $5.95 · -2.4% own

SSELL◷$49.9K

Carson Seana · EVP, General…Feb 27

8,388 sh @ $5.95 · -1.0% own

FTAX$290.9K

Charhon Jean-Jacques · EVP, CFOFeb 27

49,060 sh @ $5.93 · -6.5% own

FTAX◷$156.1K

Carson Seana · EVP, General…Feb 27

26,326 sh @ $5.93 · -3.3% own

FTAX$492.7K

Appio Thomas · Chief Executive…Feb 27

83,093 sh @ $5.93 · -2.3% own

FTAX$106.2K

Lenar Aimee J. · EVP, US PharmaFeb 26

17,578 sh @ $6.04 · -4.2% own

FTAX◷$194.6K

Carson Seana · EVP, General…Feb 26

32,211 sh @ $6.04 · -3.8% own

FTAX$217.3K

Charhon Jean-Jacques · EVP, CFOFeb 26

35,977 sh @ $6.04 · -4.5% own

FTAX$703.7K

Appio Thomas · Chief Executive…Feb 26

116,502 sh @ $6.04 · -3.1% own

AGRANT—

Lee Steven Hyosig · SVP, Controller &…Feb 25

45,868 sh · +167.6% own

AGRANT—

Lenar Aimee J. · EVP, US PharmaFeb 25

157,139 sh · +60.3% own

AGRANT◷—

Carson Seana · EVP, General…Feb 25

212,350 sh · +33.3% own

AGRANT—

Charhon Jean-Jacques · EVP, CFOFeb 25

276,055 sh · +53.6% own

AGRANT—

Appio Thomas · Chief Executive…Feb 25

815,425 sh · +27.9% own

AGRANT—

Carson Seana · EVP, General…Feb 9

137,922 sh · +27.6% own

AGRANT—

Appio Thomas · Chief Executive…Feb 9

1.1M sh · +63.8% own

AGRANT—

Paulson John · DirectorDec 31, 2025

8,992 sh · +2.6% own

AGRANT—

Leung Sandra · DirectorDec 31, 2025

4,586 sh · +13.6% own

AGRANT—

Wechsler Amy B · DirectorDec 31, 2025

989 sh · +0.4% own

PBUY★$15.6M

Paulson & Co. Inc. · 10% OwnerNov 25, 2025

2.5M sh @ $6.25 · +3.5% own

AGRANT—

Leung Sandra · DirectorSep 30, 2025

3,673 sh · +12.2% own

AGRANT—

Wechsler Amy B · DirectorSep 30, 2025

1,065 sh · +0.4% own

SSELL◷$97.7K

Carson Seana · EVP, General…Sep 8, 2025

13,370 sh @ $7.31 · -2.6% own

FTAX◷$377.3K

Carson Seana · EVP, General…Sep 5, 2025

51,337 sh @ $7.35 · -9.1% own

SSELL$121.9K

Lee Frank D. · DirectorAug 21, 2025

15,912 sh @ $7.66 · -17.7% own

PBUY▲$312.5M

Paulson John · DirectorAug 14, 2025

34.7M sh @ $9.00 · +96.4% own

PBUY$610K

Paulson John · DirectorAug 13, 2025

86,409 sh @ $7.06 · +0.2% own

PBUY$8M

Paulson John · DirectorAug 12, 2025

1.2M sh @ $6.88 · +3.3% own

PBUY$12.7M

Paulson John · DirectorAug 11, 2025

2M sh @ $6.35 · +6.1% own

AGRANT—

Goettler Michael · DirectorJul 25, 2025

30,149 sh

AGRANT—

Leung Sandra · DirectorJul 25, 2025

30,149 sh

AGRANT—

Lenar Aimee J. · EVP, US PharmaJul 17, 2025

30,847 sh · +13.4% own

FTAX$146K

Lenar Aimee J. · EVP, US PharmaJul 15, 2025

22,736 sh @ $6.42 · -9.0% own

AGRANT—

Lee Steven Hyosig · SVP, Controller &…Jul 14, 2025

27,371 sh

AGRANT—

Paulson John · DirectorJun 30, 2025

9,384 sh · +2.8% own

AGRANT—

Icahn Brett · DirectorJun 30, 2025

4,034 sh · +1.9% own

AGRANT—

Wechsler Amy B · DirectorJun 30, 2025

1,032 sh · +0.4% own

PBUY▲$21.2M

Paulson John · DirectorJun 13, 2025

3.6M sh @ $5.94 · +12.2% own

PBUY$5.5M

Paulson John · DirectorJun 12, 2025

1M sh @ $5.47 · +3.6% own

PBUY$5.4M

Paulson John · DirectorJun 11, 2025

1M sh @ $5.24 · +3.8% own

PBUY$3.8M

Paulson John · DirectorJun 10, 2025

754,134 sh @ $5.05 · +2.9% own

AGRANT—

Garcia Christian A · DirectorMay 16, 2025

54,347 sh · +153.7% own

AGRANT—

Icahn Brett · DirectorMay 16, 2025

54,347 sh · +33.6% own

AGRANT—

Kavanagh Sarah B · DirectorMay 16, 2025

54,347 sh · +29.9% own

AGRANT—

Lee Frank D. · DirectorMay 16, 2025

54,347 sh · +153.7% own

AGRANT—

Miller Steven D · DirectorMay 16, 2025

54,347 sh · +31.1% own

AGRANT—

Mulligan Richard · DirectorMay 16, 2025

54,347 sh · +53.7% own

AGRANT—

Paulson John · DirectorMay 16, 2025

54,347 sh · +19.6% own

AGRANT—

Power Robert N · DirectorMay 16, 2025

54,347 sh · +27.1% own

AGRANT—

Wechsler Amy B · DirectorMay 16, 2025

54,347 sh · +26.0% own

Filing record

How quickly insiders here report their trades. Section 16 allows two business days from the transaction.

All 58 filings we hold were filed within the two-business-day deadline.

Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings

Insiders at this company

Everyone who has filed a Form 4 for this issuer.

More biotech & pharma companies

Other issuers in the same industry with insider filings on record.

Whole sector →